European Pharmaceutical Review Issue 1 2026

Included in Issue 1 of European Pharmaceutical Review:

SOLVENTS

ICH Q3C - Residual Solvents: current status

David Elder

David P Elder Consultancy

 

MASS SPECTROMETRY

High-resolution ion mobility mass spectrometry: a new dimension for oligonucleotide characterisation

Tao Chen

Molly Blevins

Christopher Crittenden

Genentech

 

APPLICATION NOTE

Automating ion chromatography for reliable routine analysis

Dr Gesa Schad

Shimadzu

 

CLINICAL TRIALS

The Bayesian edge: how the new FDA guidance is enabling nimble, efficient clinical trials

Dr Stacy Lindborg

IMUNON

 

SUSTAINABILITY

The implementation of biodiversity footprinting – examining supply chains

Dr Tara Garraty

Tunley Environmental

 

MANUFACTURING

When AAV innovation meets manufacturing reality

Daphné Bocciarelli

eXmoor Pharma

 

ENVIRONMENTAL MONITORING IDF

Moving towards real-time insights in aseptic manufacturing

Dr Jennifer Isken

Aleš Dimnik

Novartis

 

TMSI: a novel, AI-driven alternative microbiological method for microorganism detection, enumeration and identification

Alexandre Banon

Ali Keshavarzi

Arthur Vivé

Emilia Humeau

Ludovic de Boilevin Kayl

Maiwenn Lefebvre

Marine Pottier

Maxime Mistretta

Michael J Miller

Olivia Traoré

Valentina Di Proietto

Spore.Bio

 

CELL THERAPY

Scaling complex cell therapies from clinical to commercial

Lisa Leslie and Steven Tan

FUJIFILM Biotechnologies

 

BIOPROCESS/BIOPRODUCTION

Accelerating consistent, stable cell line development with targeted integration

Tao Sun

Xiaoyue Chen

Hang Zhou

Fei Chen

WuXi Biologics

 

LYOPHILISATION

Product temperature measurement in freeze drying: back to basics

Johanna Herzog and Henning Gieseler

Friedrich-Alexander University (FAU) Erlangen-Nürnberg

 

EVENT PREVIEW
The Future of Bio/Pharmaceutical Analysis 2026: what to expect from this year’s virtual summit

European Pharmaceutical Review

 

DRUG DELIVERY IDF

EXPERT VIEW

Dissolution enhancement via solid-dose delivery of lipid-based formulations

JRS Pharma

 

Mechanically targeted drug delivery for stroke: moving from clot centric care to collateral therapeutics

Daniel Beard

University of Newcastle

Netanel Korin

Technion–Israel Institute of Technology

Dr Donald Ingber

Harvard University

 

FEATURE PARTNERSHIP

Lipid formulation development: why softgels are the technology of choice

Thermofisher Scientific

 

GUIDE TO TESTING

More than recombinant – it’s recombinant cascade

ACC

 

GUIDE TO TESTING

From ‘What is it?’ to ‘What does it mean?’

Duncan Barlow

Charles River

 

PRODUCT HUB

Lipid formulation development: why softgels are the technology of choice

MVG AG

 

APPLICATION NOTE

Robust, high-throughput automated solution for water endotoxin testing

Jonathan Schubert, Luca Di Bello, Youli Stepanov and Paola Vigilanza

bioMérieux

 

APPLICATION NOTE

Smart manufacturing and beyond: the Tri-Integrity and the support to quality management maturity for Industry 4.0.

Yokogawa Europe B.V